Dracaena cochinchinensis

Ethnobotanical Studies

Studies

Combining Different Natural Plant Extracts to Stabilize the Antioxidative Activity of Dragon's Blood.

Su YZ and Lu PL (2024).
Life (Basel).
DOI:
10.3390/life14070786
PubMed:
39063541

Synergy of botanical drug extracts from Dracaena cochinchinensis stemwood and Ardisia elliptica fruit in multifunctional effects on neuroprotection and anti-inflammation.

Immunology
Ospondpant D et al (2024).
Front Pharmacol.
DOI:
10.3389/fphar.2024.1399549
PubMed:
38751783

Screening and validation of reference genes in Dracaena cochinchinensis using quantitative real-time PCR.

Summary

Dragon's blood, a valuable traditional medicine, is limited by the endangered Dracaena species. Identifying stable reference genes for gene expression analysis can boost artificial production and research on flavonoid biosynthesis pathways.

Genetics
Gao S et al (2024).
Sci Rep.
DOI:
10.1038/s41598-024-52754-5
PubMed:
38486003

Comprehensive metabolome characterization and comparison between two sources of Dragon's blood by integrating liquid chromatography/mass spectrometry and chemometrics.

Phytochemistry
Lou J et al (2024).
Anal Bioanal Chem.
DOI:
10.1007/s00216-024-05159-2
PubMed:
38279012

Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways.

Liu Y et al (2023).
Front Cell Dev Biol.
DOI:
10.3389/fcell.2023.1202888
PubMed:
37675145

Loureirin C extracted from Dracaena cochinchinensis S.C. Chen prevents rotaviral diarrhea in mice by inhibiting the intestinal Ca(2+)-activated Cl(-) channels.

Gastroenterology
Guo SC et al (2024).
J Ethnopharmacol.
DOI:
10.1016/j.jep.2023.117077
PubMed:
37625605

The extracts of Dracaena cochinchinensis stemwood suppress inflammatory response and phagocytosis in lipopolysaccharide-activated microglial cells.

Immunology
Ospondpant D et al (2023).
Phytomedicine.
DOI:
10.1016/j.phymed.2023.154936
PubMed:
37385071

Preclinical evaluation of antimalarial activity of CPF-1 formulation as an alternative choice for the treatment of malaria.

Chaniad P et al (2023).
BMC Complement Med Ther.
DOI:
10.1186/s12906-023-03973-2
PubMed:
37143036

DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21.

GeneticsPhytochemistry
Tian Y et al (2023).
Biochem Pharmacol.
DOI:
10.1016/j.bcp.2023.115518
PubMed:
36966937

A new 1,4-benzoxazine derivative produced by endophytic Colletotrichum gloeosporioides B-142.

Zhang B et al (2024).
Nat Prod Res.
DOI:
10.1080/14786419.2022.2141735
PubMed:
36323318

Chinese dragon's blood ethyl acetate extract suppresses gastric cancer progression through induction of apoptosis and autophagy mediated by activation of MAPK and downregulation of the mTOR-Beclin1 signalling cascade.

CancerGastroenterologyImmunology
Ouyang L et al (2023).
Phytother Res.
DOI:
10.1002/ptr.7652
PubMed:
36245270

A chromosome-level genome assembly for Dracaena cochinchinensis reveals the molecular basis of its longevity and formation of dragon's blood.

Genetics
Xu Y et al (2022).
Plant Commun.
DOI:
10.1016/j.xplc.2022.100456
PubMed:
36196059

Dracaena cochinchinensis stemwood extracts inhibit amyloid-β fibril formation and promote neuronal cell differentiation.

Neuroscience
Ospondpant D et al (2022).
Front Pharmacol.
DOI:
10.3389/fphar.2022.943638
PubMed:
36147317

Transcriptomics and Metabolomics Analyses Reveal Defensive Responses and Flavonoid Biosynthesis of Dracaena cochinchinensis (Lour.) S. C. Chen under Wound Stress in Natural Conditions.

GeneticsPhytochemistry
Liu Y et al (2022).
Molecules.
DOI:
10.3390/molecules27144514
PubMed:
35889387

FISH-Based Karyotype Analyses of Four Dracaena Species.

Zhao H et al (2021).
Cytogenet Genome Res.
DOI:
10.1159/000516897
PubMed:
34289478

Dihydrochalcones and homoisoflavanes from the red resin of Dracaena cochinchinensis (Chinese dragon's blood).

Su XQ et al (2014).
Fitoterapia.
DOI:
10.1016/j.fitote.2014.09.006
PubMed:
25218969